Dr. Michael E. Widlansky, MD

Dr. Widlansky practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Widlansky's NPI, 1467568220, was assigned on August 22, 2006. Dr. Widlansky graduated from University of Michigan Medical School in 1999. Dr. Widlansky holds Wisconsin license 50715.

Dr. Widlansky's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Widlansky's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians. Dmand AI also links Dr. Widlansky to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Widlansky practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Widlansky's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Widlansky's licenses on file in 2 states: Wisconsin and Massachusetts.

CMS data shows 263 Medicare services from Dr. Widlansky across 5 procedure codes in 2024, for 209 Medicare patients. Medicare paid $10,801 for them.

CMS counts 209 Medicare patients who saw Dr. Widlansky in 2024. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Widlansky's median patient age at 65, with 52% women.

In 2024, Dr. Widlansky wrote 43 Medicare Part D claims for 17 patients. 88% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $271 in total drug cost.

Dr. Widlansky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 67 papers to Dr. Widlansky, published from 2010 to 2025. 2024 was the busiest year, with 7. The most frequent topics are Endothelium, Vascular, Vasodilation and Brachial Artery. Dr. Widlansky has published most often in Vasc Med. Dr. Widlansky's most frequent co-authors are Kodlipet C. Dharmashankar, MD, David D. Gutterman, MD and Sudhi Tyagi, MD.

Dmand AI links Dr. Widlansky to 2 clinical trials. Conditions studied include Cardiovascular Diseases, Cerebral Arterial Diseases and Intracranial Arterial Diseases.

CMS Open Payments shows 7 general payments to Dr. Widlansky from 3 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 64% of the total. Amgen Inc. paid the most, $377.

Dr. Widlansky graduated from University of Michigan Medical School in 1999.